We are live on ! Find out more
JC

Jacobs & Co Portfolio holdings

AUM $1.17B
1-Year Est. Return 37.3%
This Fund
S&P 500
This Quarter Est. Return
+7.64%
1 Year Est. Return
+37.3%
3 Year Est. Return
+92.23%
5 Year Est. Return
+114.23%
10 Year Est. Return
+410.55%
AUM
$658M
AUM Growth
+$41.6M
Cap. Flow
-$2.26M
Cap. Flow %
-0.34%
Top 10 Hldgs %
27.12%
Holding
136
New
3
Increased
48
Reduced
56
Closed
10

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$2.62M
2
YUM icon
Yum! Brands
YUM
+$1.59M
3
FDX icon
FedEx
FDX
+$1.53M
4
BMY icon
Bristol-Myers Squibb
BMY
+$1.47M
5
GLW icon
Corning
GLW
+$1.12M

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$2.18M
2
CVX icon
Chevron
CVX
+$1.86M
3
META icon
Meta Platforms (Facebook)
META
+$1.69M
4
PXD
Pioneer Natural Resource Co.
PXD
+$1.02M
5
TELL
Tellurian Inc.
TELL
+$997K

Sector Composition

Rank Sector Weight
1 Technology 21.41%
2 Healthcare 18.95%
3 Industrials 13.46%
4 Communication Services 10.9%
5 Consumer Staples 10.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HON icon
26
Honeywell
HON
$77B
$9.02M 1.37%
54,056
-1,425
-3% -$233K
T icon
27
AT&T
T
$159B
$8.71M 1.32%
295,186
+6,129
+2% +$177K
MCD icon
28
McDonald's
MCD
$192B
$8.69M 1.32%
43,965
-467
-1% -$92.6K
VZ icon
29
Verizon
VZ
$195B
$8.59M 1.3%
139,835
+2,080
+2% +$125K
MMM icon
30
3M
MMM
$90.9B
$8.44M 1.28%
57,237
+4,093
+8% +$573K
ABT icon
31
Abbott
ABT
$183B
$7.91M 1.2%
91,074
+3,273
+4% +$274K
MKC icon
32
McCormick & Company Non-Voting
MKC
$13.7B
$7.32M 1.11%
86,242
+5,100
+6% +$422K
PFE icon
33
Pfizer
PFE
$143B
$7.15M 1.09%
192,304
+8,071
+4% +$287K
MRK icon
34
Merck
MRK
$322B
$7.04M 1.07%
81,104
+6,946
+9% +$571K
ENB icon
35
Enbridge
ENB
$119B
$6.95M 1.06%
174,706
-232
-0.1% -$8.66K
CVX icon
36
Chevron
CVX
$392B
$6.89M 1.05%
57,164
-15,759
-22% -$1.86M
SCHW
37
Charles Schwab
SCHW
$183B
$6.84M 1.04%
143,843
+2,699
+2% +$119K
STZ icon
38
Constellation Brands
STZ
$22.2B
$6.56M 1%
34,593
+4,872
+16% +$920K
GLW icon
39
Corning
GLW
$119B
$6.36M 0.97%
218,524
+38,505
+21% +$1.12M
IBM icon
40
IBM
IBM
$211B
$6.34M 0.96%
49,518
+4,977
+11% +$647K
BUD icon
41
AB InBev
BUD
$170B
$6.23M 0.95%
75,957
+12,071
+19% +$1.01M
WBA
42
DELISTED
Walgreens Boots Alliance
WBA
$6.18M 0.94%
104,879
+8,303
+9% +$479K
GOOGL icon
43
Alphabet (Google) Class A
GOOGL
$4.36T
$6.01M 0.91%
89,800
+480
+0.5% +$31K
BMY icon
44
Bristol-Myers Squibb
BMY
$133B
$6.01M 0.91%
93,667
+25,637
+38% +$1.47M
PG icon
45
Procter & Gamble
PG
$336B
$6M 0.91%
48,059
+1,470
+3% +$180K
DE icon
46
Deere & Co
DE
$160B
$5.94M 0.9%
34,289
-691
-2% -$119K
AMAT icon
47
Applied Materials
AMAT
$403B
$5.91M 0.9%
96,805
-6,605
-6% -$371K
ZBH icon
48
Zimmer Biomet
ZBH
$18.2B
$5.51M 0.84%
37,915
-721
-2% -$99.5K
ADP icon
49
Automatic Data Processing
ADP
$106B
$5.38M 0.82%
31,532
+3,466
+12% +$574K
FDX icon
50
FedEx
FDX
$72.7B
$5.33M 0.81%
35,218
+9,929
+39% +$1.53M
1
2
3 4 5

Similar funds

OCAI
O'Connor Alternative Investments New York $1.17B AUM
BONST
Bank of Nova Scotia Trust Toronto, Ontario, Canada $1.16B AUM 27.04% 1-Year Est. Return
AMI
Amica Mutual Insurance Providence, Rhode Island $1.16B AUM 21.34% 1-Year Est. Return
GAB
German American Bancorp Jasper, Indiana $1.16B AUM 25.7% 1-Year Est. Return
SCP
Sandhill Capital Partners Buffalo, New York $1.16B AUM 12.37% 1-Year Est. Return
FG
Fiduciary Group Savannah, Georgia $1.17B AUM 16.92% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
AC
AltraVue Capital Bellevue, Washington $1.16B AUM 46.45% 1-Year Est. Return

Jacobs & Co's Q4 2019 Portfolio in Review

As of Q4 2019, Jacobs & Co held 136 positions worth $658M, up 6.8% from $617M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Jacobs & Co's Q4 2019 filing shows 3 new, 48 increased, 56 reduced and 10 closed positions. Its largest new stake was Biogen: 9,440 shares worth $2.8M. The largest sale was Celgene Corp, an estimated $2.18M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Industrials.

  • Jacobs & Co's largest Q4 2019 buy was Biogen: 9,440 shares worth $2.8M.
  • Jacobs & Co added most to Yum! Brands in Q4 2019, an estimated $1.59M increase.
  • Jacobs & Co's biggest Q4 2019 reduction was Chevron, cutting an estimated $1.86M.
  • Jacobs & Co fully exited Celgene Corp in Q4 2019, selling an estimated $2.18M.
  • Jacobs & Co's ten largest holdings make up 27% of its $658M portfolio in Q4 2019.
  • Jacobs & Co opened 3 new positions and closed 10 in Q4 2019.
  • Jacobs & Co's portfolio value rose 6.8% quarter-over-quarter to $658M.

Based on Jacobs & Co's 13F filing for Q4 2019, filed 29 Jan 2020.